News
Press Room
05 / 10 / 2009
COS granted for 5 products
The European Council has granted Crystal Pharma the Certificate of Suitability for 5 products so far, Beclomethasone Dipropionate, Betamethasone Dipropionate, Betamethasone Sodium Phosphate, Betamethasone Valerate, Budesonide, and Mometasone Furoate
Press Room
Press Room / Anteriores-
Ragactives has been granted with COS/CEP for Pramipexole last June 2011.
-
Ragactives has been granted with COS/CEP for Dorzolamide September 2011
-
Gadea Pharmaceutical Group has invested in a production facility for final dossage forms.
-
COS for Beclomethasone Dipropionate granted
-
The FDA successfully inspects Crystal Pharma. This is Crystal Pharma second FDA inspection.
-
Crystal Pharma has been FDA successfully inspected, for the sterile by filtration facility.
-
High potency steroids. Crystal Pharma opens a High Potency Steroids Unit.
Fairs
07 / 05 / 2012
Read more...
Gadea Grupo Farmacéutico, will be exhibiting at CPhI Madrid 2012, with stand number 3C30. You are welcome to come along!